Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent
Journal of Molecular Recognition · 2024-03 · 37 (2)
DOI: 10.1002/jmr.3074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Recognition, online erschienen am 03.01.2024. Verfasst von V S Kunjumol und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering, University of Technology and Applied Science, Shinas, Oman. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: International Research Centre (IRC), Kalasalingam Academy of Research and Education, Hearing Industry Research Consortium.
Abstract (Originalsprache)
6‐Bromobenzimidazole (6BBZ) has been calculated in this study utilizing the 6‐311++G(d,p) basis set and the Becke‐3‐Lee‐Yang‐Parr density functional approaches. The basic frequencies and geometric optimization are known. FTIR, FT‐Raman, and UV–Vis spectra of the substance are compared between its computed and observed values. The energy gap between highest occupied molecular orbital–lowest unoccupied molecular orbital and molecule electrostatic potentials has been represented by charge density distributions that may be associated with the biological response. Time‐dependent density functional theory calculations in the gas phase and dimethyl sulfoxide were carried out to ascertain the electronic properties and energy gap values using the same basis set. Molecular orbital contributions are investigated using the overlap population, partial, and total densities of states. Natural bond analysis was found to have strong electron delocalization by means of π(C4–C9) → π*(C5–C6), LP (N1) → π*(C7–C8), and LP(Br12) → π*(C5–C6) interactions. The Fukui function and Mulliken analysis have been explored on the atomic charges of the molecule. The nuclear magnetic resonance chemical shifts for 1 H and 13 C have been computed using the gauge‐independent atomic orbital technique. With the highest binding affinity (−6.2 kcal mol −1 ) against estrogen sulfotransferase receptor (PDB ID: 1AQU) and low IC 50 value of 17.23 μg/mL, 6BBZ demonstrated potent action against the MCF‐7 breast cancer cell line. Studies on the antibacterial activity and ADMET prediction of the molecule have also been carried out.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Engineering, University of Technology and Applied Science, Shinas, Oman.
- Department of Physics, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India.
ORCID-Profile: S Jeyavijayan
Förderung
- International Research Centre (IRC), Kalasalingam Academy of Research and Education
- Hearing Industry Research Consortium
Zitieren
APA
Kunjumol, V. S., Jeyavijayan, S., Sumathi, S., & Karthik, N. (2024). Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent. Journal of Molecular Recognition, 37(2). https://doi.org/10.1002/jmr.3074
Vancouver
Kunjumol VS, Jeyavijayan S, Sumathi S, Karthik N. Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent. Journal of Molecular Recognition. 2024;37(2). doi:10.1002/jmr.3074
BibTeX
@article{Kunjumol2024,
author = {Kunjumol, V S and Jeyavijayan, S and Sumathi, S and Karthik, N},
title = {Spectroscopic, computational, cytotoxicity, and docking studies of 6‐bromobenzimidazole as anti‐breast cancer agent},
journal = {Journal of Molecular Recognition},
year = {2024},
volume = {37},
number = {2},
doi = {10.1002/jmr.3074}
}
EUVIMED